JPMorgan analyst David Perry raised the firm’s price target on Exosens (EXOSF) to EUR 60 from EUR 54 and keeps an Overweight rating on the shares.
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds